Ekso Bionics Holdings Inc
NASDAQ:CHRN
Ekso Bionics Holdings Inc
NASDAQ:CHRN
Price:
23.36
USD
22.69%
Market Closed
Market Cap:
$83.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Ekso Bionics Holdings Inc
NASDAQ:CHRN
|
US |
|
Rheinmetall AG
F:RHMB
|
DE |
|
S
|
Santana Minerals Ltd
OTC:SEQP
|
AU |
|
WEG SA
BOVESPA:WEGE3
|
BR |
|
PSP Projects Ltd
NSE:PSPPROJECT
|
IN |
|
P
|
Peugeot Invest SA
F:FFP
|
FR |
|
Hexagon Purus ASA
F:0QJ
|
NO |
|
C
|
CanAlaska Uranium Ltd
F:DH7N
|
CA |
|
M
|
MorphoSys AG
SWB:MOR
|
DE |
Wall St Price Targets
CHRN Price Targets Summary
Ekso Bionics Holdings Inc
Ekso Bionics Holdings Inc
Wall Street analysts forecast CHRN stock price to drop over the next 12 months.
According to Wall Street analysts, the average 1-year price target for CHRN is 9.69 USD with a low forecast of 9.6 USD and a high forecast of 9.98 USD.
Lowest Forecast
Price Target
9.6
USD
59% Downside
Average Forecast
Price Target
9.69
USD
59% Downside
Highest Forecast
Price Target
9.98
USD
57% Downside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CHRN's stock price target?
Price Target
9.69
USD
9.69
USD
According to Wall Street analysts, the average 1-year price target for CHRN is 9.69 USD with a low forecast of 9.6 USD and a high forecast of 9.98 USD.
What is the Revenue forecast for Ekso Bionics Holdings Inc?
Projected CAGR
35%
35%
Over the last 11 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 3 years is 35%.
